Remifentanil Completed Phase 4 Trials for Autonomic Nervous System Activity Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT01714388Vagotonic Effect of Remifentanil and Autonomic Nervous System Activity.